Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies low-dose acetylsalicylic acid in treating patients with
stage I-III non-small cell lung cancer. Studying samples of urine and blood from patients
with cancer in the laboratory may help doctors learn more about changes in biomarkers that
occur during treatment with acetylsalicylic acid